← FDA DRUG APPROVALS

FDA ANDA · ANDA208481

ITRACONAZOLE

Sponsor: APOTEX

APPLICATION
ANDA208481
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-02
LATEST ACTION
2025-06-16
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ITRACONAZOLEDiscontinued
ITRACONAZOLE 10MG/ML · SOLUTION · ORAL

Approval history

2025-06-16Labeling · Supplement 3 · standardAP
2025-06-16Labeling · Supplement 4 · standardAP
2024-09-30Labeling · Supplement 1 · standardAP
2024-09-30Labeling · Supplement 2 · standardAP
2019-08-02UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →